We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- Receptor-ligand binding
- Agonists vs antagonists
- Allosteric modulation
- Affinity and specificity
- Receptor occupancy theory
- Clinical drug examples
- Receptor theory in drug development
Talk Citation
(2026, September 30). Receptor theory in pharmacology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 1, 2026, from https://doi.org/10.69645/OPMM6704.Export Citation (RIS)
Publication History
- Published on September 30, 2026
Financial Disclosures
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
In this talk, we turn
our attention to receptor
theory in pharmacology,
framing our discussion around
receptor ligand
binding principles,
distinctions among full
and partial agonists,
as well as antagonists,
and the growing importance of
allosteric modulation
in pharmacology.
We will discuss how affinity and
specificity influence drug
receptor interactions
and explain
quantitative concepts
like the receptor
occupancy theory.
Clinical examples will
illustrate how different ligands
and modulators affect
therapeutic selectivity
and drug safety.
Lastly, these foundational
concepts will
be linked to the development
and optimization of safer,
more effective drug therapies.
Understanding how
drugs interact with
cellular receptors is central
to modern pharmacology,
shaping how we develop
and use medicines.
Receptors are usually
proteins on cell membranes
that recognize and bind
specific molecules
called ligands,
such as neurotransmitters,
hormones, or drugs.
This interaction triggers
downstream cellular effects,
producing physiological
responses.
In this lecture, we will
explore receptor
binding principles,
ligand categories,
allosteric modulation,
and clinical examples.
At the molecular level,
drug receptor interactions are
governed by affinity
and specificity.
Affinity describes how
tightly a drug binds,
while specificity
ensures selective
binding to certain
receptor sub types,
minimizing off target effects.
Ligand binding can induce